Mobicort tablets
Category:
The drug is intended for symptomatic therapy, reducing pain and inflammation at the time of use, and does not affect the progression of the disease. Parenterally used as initial therapy and short-term symptomatic treatment. Subsequently, treatment is continued with the use of oral dosage forms.
each tablet contains:
- Meloxicam 15 mg;
- Cyanocobalamin 2.5 mg;
- Betamethasone sodium phosphate eq. betamethasone 0.30 mg.
- rheumatoid arthritis;
- inflammatory and degenerative diseases of the musculoskeletal system, such as arthropathy, dorsopathies (for example, sciatica, lumboischialgia, cervical brachialgia, brachial periarthritis, Reiter's syndrome, ankylosing spondylitis (Bechterew's disease), acute tenosynovitis), accompanied by pain;
- symptomatic treatment of osteoarthritis (arthrosis, degenerative joint diseases), incl. with a pain component.
Directions for use and dosage: The drug is administered orally. The doctor sets the dosage regimen individually, depending on the intensity of pain and the severity of the inflammatory process. The drug should not be used simultaneously with other NSAIDs. The total daily dose of the drug used in the form of different dosage forms should not exceed the dose (7.5 mg-15 mg for meloxicam, respectively) depending on the intensity of pain and the severity of the inflammatory process. IM administration of the drug is indicated only during the first 2-3 days of therapy. Subsequently, treatment is continued with the use of oral dosage forms.
Taking the drug orally: It is recommended to take 1 tablet 1 time per day, with meals. The tablet must be taken with water. The course of treatment is determined by the attending physician depending on the severity of the symptoms of the disease.
Call center
We are always ready to answer your calls or messages, we will be happy to cooperate with you.
Subscribe to Newsletter
